青蒿对湿热证疟疾小鼠的多靶点干预作用
批准号:
82074301
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
邓长生
依托单位:
学科分类:
证候基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
邓长生
中文摘要
疟疾是一种严重危害人类生命健康的传染病。现全球疟疾消除停滞不前,青蒿素复方治疟失败病例逐年增加,各类抗疟药物的抗性虫株迅速在世范围内蔓延,对全球的疟疾防治和消除形成巨大威胁。黄花蒿入药,清热、解暑、截疟、凉血,广泛分布于世界各地,包括欧洲中东部和亚洲北部,以及地中海、北非、亚洲南部及西南部各国,亦可适种于湿热疟区。现代临床研究证实青蒿干枝叶泡水,治疟效果高于或等于青蒿素复方。从古至今,青蒿抗疟效果佳,能有效防止药物抗性产生。但青蒿素抗疟机理尚不明确,青蒿素原药激活、靶标都不确定。故本研究拟利用生物信息技术,探索青蒿治疗湿热疟疾的多成分、多靶点、多通路的潜在作用机制,并进行动物实验验证;同时体外培育青蒿素、哌喹鼠疟抗性株,进行全基因分析,探索青蒿素抗性产生机制。该研究将加深对青蒿素和青蒿中药的认识,对指导合理用药、提高临床疗效、防止抗药株的产生、发现新的抗疟药物都具有重要意义。
英文摘要
Malaria is an infectious disease seriously endangering human life and health. Today, global malaria elimination remains stagnant, the number of malaria cases failing to respond to artemisinin-based therapy keeps increasing every year, and drug-resistant malaria strains are spreading rapidly around the world posing a great threat to malaria control and elimination efforts globally. Artemisia annua Linn clears away heat, relieves summer heat, treats malaria and cools blood. It is widely distributed throughout the world, including central and eastern Europe, northern Asia, as well as countries in the Mediterranean Sea, North Africa, and southern and southwestern Asia. It can also grow in hot and humid malarious areas. Modern clinical studies confirmed that the malaria treatment effect of dried branches and leaves of Artemisia annua soaked into water is higher than or equal to that of an Artemisinin compound. Since ancient times, Artemisia annua is efficient to treat malaria; it can effectively prevent drug resistance. However, the antimalaria mechanism of Artemisia annua is not clear, and the activation and target of Artemisinin are uncertain. Therefore, this study intends to use bioinformation technology to explore the potential mechanism of the multi-component, multi-target and multi-pathway action of Artemisia annua in the treatment of damp-heat malaria, and to carry out animal experiments to verify the above mechanism. In the meantime, the resistant strains to Artemisinin-Piperaquine are cultivated in vitro to complete genetic analysis in order to explore the resistance mechanism to Artemisinin. This study will deepen the understanding on Artemisinin and Artemisia Annua which will be of great significance in providing guidance for rational use of drugs, improving clinical efficacy, preventing the emergence of drug-resistant strains and discovering new antimalarial drugs.
疟疾是一种以按蚊叮咬或输入带疟原虫者的血液而感染的虫媒传染性疾病,该传染病严重危害部分落后及发展中国家人民的生命安全,阻碍了其社会经济的发展和我国“一带一路”战略的部署。目前,疫区多联合使用氯喹、阿莫地喹、伯氨喹和青蒿素等药物进行抗疟,但面对该地区疟疾患者经济承受力不足和疟原虫日渐产生的耐药性等问题,研发具有高治疗价值、毒性小和成本较低的新抗疟药是迫切且必要的。.由于人工合成青蒿素的成效不佳,从黄花蒿中提取仍是获得青蒿素的主要方式。现实中,非洲疫区受制于薄弱的经济和基础设施,难以大规模运用黄花蒿制备青蒿素及其衍生物进行治疗,致使全球疟疾消除停滞不前。本研究通过LC-MS结合网络药理学,探索了黄花蒿水提物中青蒿素类衍生物外辅助治疗疟疾的新物质;通过黄花蒿水提物对感染疟原虫小鼠肝脏的保护和影响补体系统,挖掘了其治疗疟疾的潜在机制;从多角度评估,确认了黄花蒿水提物治疗感染青蒿素、哌喹抗性虫株疟原虫小鼠的疗效,以期为非洲疫区低成本防控疟疾、延缓青蒿素耐药性疟原虫的产生和疟疾的临床治疗提供新思路。
基于脂质组学探索黄花蒿水提物对湿热证疟原虫作用机制研究
-
批准号:82374315
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:邓长生
-
依托单位:
湿热证鼠疟伯氏疟原虫K173抗性培育及相关基因多态性研究
-
批准号:81403295
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:邓长生
-
依托单位:
国内基金
海外基金